Literature DB >> 17589195

Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate.

David H Shepp1, Sue Curtis, James F Rooney.   

Abstract

To determine the spectrum of clinical manifestations of hypokalemia associated with tenofovir, we reviewed all reports of grades 3/4 hypokalemia received by Gilead Sciences Department of Safety and Public Health. Of 32 cases identified in 2001-2006, 23 were attributed to proximal renal tubular dysfunction, and medically significant conditions attributable to hypokalemia occurred in four, which all improved with medical management. In none of the six fatal cases did hypokalemia appear to contribute to death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589195     DOI: 10.1097/QAD.0b013e3280b07b6c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.

Authors:  Pedro Rodríguez Quesada; Laura López Esteban; Jimena Ramón García; Rocío Vázquez Sánchez; Teresa Molina García; Gabriel Gaspar Alonso-Vega; Javier Sánchez-Rubio Ferrández
Journal:  Int J Clin Pharm       Date:  2015-05-26

Review 2.  Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients.

Authors:  Carlos G Musso; Waldo H Belloso; Richard J Glassock
Journal:  World J Nephrol       Date:  2016-01-06

3.  Review of tenofovir-emtricitabine.

Authors:  Saba Woldemichael Masho; Cun-Lin Wang; Daniel E Nixon
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

4.  Hypokalemia: A potentially life-threatening complication of tenofovir therapy.

Authors:  Abhilash Koratala; Rupam Ruchi
Journal:  SAGE Open Med Case Rep       Date:  2017-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.